Quanterix Corp Cash Flow Conversion Efficiency

Latest as of June 2026: 0.011x

Quanterix Corp cash flow conversion efficiency. Based on the latest financial reports, Quanterix Corp (QTRX) has a cash flow conversion efficiency ratio of 0.011x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.59 Million) by net assets ($237.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Quanterix Corp (2015–2025)

Cash flow conversion efficiency of Quanterix Corp from 2015 to 2025. This chart illustrates how Quanterix Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Quanterix Corp for real-time trading data and today's change.

Quanterix Corp Cash Flow Conversion Ratio Explained

Quanterix Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Quanterix Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Quanterix Corp ranked by their cash flow conversion efficiency. Also see QTRX market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
RF Acquisition Corp III Ordinary Shares
NASDAQ:RFAM
0.000x
CBO Territoria S.A.
PA:CBOT
0.037x
Goliath Resources Ltd
V:GOT
-0.921x
AVerMedia Technologies Inc
TW:2417
0.036x
Lucky Cement Co
TW:1108
0.021x
Friedman Industries Inc. Common Stock
NYSE MKT:FRD
0.003x
Legacy Education Inc.
NYSE MKT:LGCY
0.023x
In The F
KO:014990
0.009x

Annual Cash Flow Conversion Efficiency for Quanterix Corp (2015–2025)

The table below shows the annual cash flow conversion efficiency of Quanterix Corp from 2015 to 2025. Review QTRX cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $295.73 Million $-77.24 Million -0.261x -145.13%
2024-12-31 $330.04 Million $-35.16 Million -0.107x -97.26%
2023-12-31 $349.96 Million $-18.90 Million -0.054x +59.95%
2022-12-31 $357.93 Million $-48.27 Million -0.135x -24.13%
2021-12-31 $440.95 Million $-47.91 Million -0.109x +4.15%
2020-12-31 $206.12 Million $-23.36 Million -0.113x +44.31%
2019-12-31 $128.66 Million $-26.19 Million -0.204x +70.55%
2018-12-31 $41.56 Million $-28.72 Million -0.691x -105.93%
2017-12-31 $65.87 Million $-22.11 Million -0.336x +74.51%
2016-12-31 $13.48 Million $-17.74 Million -1.317x -259.82%
2015-12-31 $-15.20 Million $-12.52 Million 0.824x --

About Quanterix Corp

NASDAQ:QTRX USA Medical Devices
Market Cap
$139.04 Million
Market Cap Rank
#17745 Global
#4199 in USA
Share Price
$2.94
Change (1 day)
+4.63%
52-Week Range
$2.42 - $8.06
All Time High
$90.64
About

Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measureme… Read more